This has led researchers and clinicians to investigate whether newer anti-obesity medications, including GLP-1 receptor agonists like Zepbound (tirzepatide), might offer therapeutic benefits for patients with MASLD beyond their primary indication for weight management and glycemic control
Our clinic offers a variety of state-of-the-art peptide treatments designed to address a wide range of health and wellness concerns
For semaglutide, patients can look into Novo Nordisks assistance programs, as Novo Nordisk is the manufacturer of Ozempic, Wegovy, and Rybelsus
14.4 Noncirrhotic Metabolic Dysfunction-associated Steatohepatitis with Moderate to Advanced Liver Fibrosis in Adults Treated with WEGOVY Injection Overview of Clinical Trial The efficacy of WEGOVY injection was evaluated based on an efficacy analysis at Week 72 in Study 11 (NCT#04822181), a 240-week, randomized, double-blind, placebo-controlled trial